Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node-positive breast cancer: How can we select patients?

Breast J. 2020 Sep;26(9):1869-1870. doi: 10.1111/tbj.13930. Epub 2020 Jun 10.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Axilla
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / surgery
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Lymph Node Excision
  • Lymph Nodes / diagnostic imaging
  • Lymph Nodes / surgery
  • Neoadjuvant Therapy*
  • Sentinel Lymph Node Biopsy